Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Myelodysplastic Syndrome with Excess Blasts and Fibrosis — Genomics · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Myeloid Neoplasm
Myelodysplastic Syndrome
Myelodysplastic Syndrome with Excess Blasts
Myelodysplastic Syndrome with Excess Blasts and Fibrosis

Hematologic Malignancy

Myelodysplastic Syndrome with Excess Blasts and Fibrosis

CI-CAN-00006072RAEB-FExplore in graph →

Hematologic

NCIt: C82595

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials
Research
Rankings
Sources & provenance

Genomics

Gene alteration frequencies by cohort

Data not yet available

No genomic cohort is mapped to this entity or its descendants. Frequencies come from open-access cohorts (GDC projects) and always carry their denominator (cases profiled); they are never pooled across cohorts.

What CancerIndex knows

Variants & evidence
Genes index